Royal Bank of Canada
AGL icon

Royal Bank of Canada’s Agilon Health AGL Stock Holding History

Royal Bank of Canada’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Buy
2,368
+1,637
+224% +$26.5K ﹤0.01% 5911
2025
Q4 		$13K Buy
731
+290
+66% +$5.62K ﹤0.01% 6264
2025
Q3 		$11K Sell
441
-11,241
-96% -$425K ﹤0.01% 6440
2025
Q2 		$672K Buy
11,682
+10,899
+1,392% +$874K ﹤0.01% 4237
2025
Q1 		$85K Sell
783
-47
-6% -$4.09K ﹤0.01% 5312
2024
Q4 		$40K Sell
830
-1,301
-61% -$78.6K ﹤0.01% 5788
2024
Q3 		$209K Buy
2,131
+106
+5% +$13.7K ﹤0.01% 4783
2024
Q2 		$331K Buy
2,025
+801
+65% +$114K ﹤0.01% 4338
2024
Q1 		$187K Buy
1,224
+3
+0.2% +$499 ﹤0.01% 4741
2023
Q4 		$383K Buy
1,221
+178
+17% +$64.4K ﹤0.01% 4501
2023
Q3 		$463K Buy
1,043
+36
+4% +$16.3K ﹤0.01% 4093
2023
Q2 		$437K Buy
1,007
+217
+27% +$122K ﹤0.01% 4051
2023
Q1 		$469K Sell
790
-35
-4% -$19.6K ﹤0.01% 3910
2022
Q4 		$333K Sell
825
-31
-4% -$14.5K ﹤0.01% 4446
2022
Q3 		$501K Buy
856
+84
+11% +$50.3K ﹤0.01% 4038
2022
Q2 		$421K Buy
772
+83
+12% +$42K ﹤0.01% 4230
2022
Q1 		$436K Buy
689
+225
+48% +$116K ﹤0.01% 4379
2021
Q4 		$313K Buy
464
+365
+369% +$222K ﹤0.01% 4892
2021
Q3 		$65K Buy
99
+50
+102% +$42.7K ﹤0.01% 5995
2021
Q2 		$50K Buy
+49
New +$42.9K ﹤0.01% 6033

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Royal Bank of Canada's AGL Position: Q1 2026 in Review

Royal Bank of Canada increased its Agilon Health (AGL) stake by 224% in Q1 2026, buying an estimated $26.5K and bringing the position to 2,368 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #5911.

Royal Bank of Canada first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $672K in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Royal Bank of Canada held 2,368 shares of Agilon Health worth $19K as of Q1 2026.
  • Royal Bank of Canada bought 1,637 Agilon Health shares in Q1 2026, an estimated $26.5K.
  • Agilon Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5911 holding.
  • Royal Bank of Canada first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's Agilon Health position peaked at $672K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.